Home > Register for programs > Live Meetings    
Pharmacists Roadmap to Pain Management

Zero Tolerance for HAIs:
Pharmacists Take the Next Step

Outcomes Now Available

Herpes Zoster Vaccination: Clinical Update

  

Addressing Opioid Induced Constipation (OIC)

Pain Management Point of Care

OPAT Point of Care

Antifungal Stewardship
Point of Care


  
wbenc  


 Overactive Bladder: Patient-Centered Approaches in Improving Outcomes
 Marriott Marquis
901 Massachusetts Ave.
Washington, DC
Meeting Room: Liberty Salons N,O,P
 Thursday, October 23, 2014
 6:00 AM  -  8:00 AM

Registration Faculty
 

CREDIT HOURS


2.0
 
EDUCATIONAL OVERVIEW

Overactive bladder (OAB) is a chronic, debilitating condition that impacts approximately 34 million Americans. Though OAB is a common condition, it is estimated that less than 30% of patients receive treatment, likely attributed to the reluctance of patients to talk to their healthcare providers about the condition. Left untreated, OAB can significantly impact a patient’s quality of life, including physical, psychological, social, domestic, occupational, and sexual aspects. The economic cost of OAB is also staggering, estimated at nearly $66 billion annually in the US.

To improve patient quality of care and satisfaction, clinicians should take a proactive approach to screen patients and provide education regarding OAB. This should include information about normal lower urinary tract function, what is known about OAB, the benefits vs. risks/burdens of the available treatment options, and the importance of adherence to treatment. It is also essential for clinicians to educate their patients on expected outcomes from current therapeutic options and develop realistic patient-centered goals for treatment.

As the science relevant to OAB evolves and improves, and the literature continually expands, PCPs must stay up-to-date on new treatment strategies and therapeutic options. With the implementation of the Affordable Care Act, many who were previously uninsured will now pursue medical assistance to manage long-standing signs and symptoms. Often-times, the first provider-patient contact will be with a PCP, who will be in an ideal position to screen, diagnose and treat patients with OAB.
The CME symposium is designed to open and conclude with an interactive patient case scenario that reflects the challenges and decision-making process that occurs regularly in clinical practice when caring for patients with OAB.

TARGET AUDIENCE


This educational activity is designed as a comprehensive approach to address the practice needs of primary care providers, including family physicians, physician assistants, nurse practitioners, and allied healthcare professionals, who are at the forefront of caring for adult patients who may be suffering from OAB. This program will target healthcare providers who are involved in the screening and management of patients experiencing symptoms of OAB.

LEARNING OBJECTIVES


Healthcare professionals participating in this educational activity will be able at its conclusion to:
  • Identify patients with OAB through screening and appropriate diagnostic techniques
  • Evaluate current treatment options to individualize therapy based on effectiveness and adverse event profile
  • Implement strategies to regularly assess patient satisfaction with OAB treatment and adjust therapy when necessary to improve effectiveness and adherence

PROGRAM AGENDA


Registration: 6:00 AM – 6:30 AM
Educational Program: 6:30 AM – 8:00 AM
6:30 AM – 6:40 AM The Burden of Overactive Bladder
6:40 AM – 7:50 AM Patient-Centered Approaches Toward Improved Quality of Life

OAB practice case 1
Epidemiology, Screening, and Diagnosis
Back to OAB practice case 1 discussion
Patrick J. Shenot, MD

OAB practice case 2
Initiating Treatment
Back to OAB practice case 2 discussion
Mickey Karram, MD

OAB practice case 3
When the Patient Does Not Reach Treatment Goals:
What Do You Do?

Back to OAB practice case 3 discussion
Scott A. MacDiarmid, MD
7:50 AM – 8:00 AM Open Forum: Q and A

FEE 


There is no fee to participate in this educational activity.

ACCREDITATION


Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Center for Independent Healthcare Education (Center) and Vemco MedEd. Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Center designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP Prescribed Credits
This live activity, Overactive Bladder: Patient-Centered Approaches in Improving Outcomes, with a beginning date of October 23, 2014, has been reviewed and is acceptable for up to 2 Prescribed credits by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For questions regarding accreditation, please contact info@jointsponsor.com.


INSTRUCTIONS FOR CREDIT

To receive a Certificate of Credit, participants must register for the symposium, document attendance, and complete and return the evaluation form.

Physicians: A Certificate of Credit will be emailed to you 4 weeks after the symposium.

DISCLOSURE OF CONFLICTS OF INTEREST


In accordance with policies set forth by the Accreditation Council for Continuing Medical Education (ACCME), Center for Independent Healthcare Education requires all faculty members and spouses/significant others with an opportunity to affect the content of a continuing education activity to disclose any relevant financial relationships during the past 12 months with commercial interests. A commercial interest is any entity producing, marketing, reselling or distributing health care goods or services consumed by or used on patients. Relationships with commercial interests and conflicts of interest resulting from those relationships must be revealed to the audience and resolved prior to the activity.

Relevant relationships include roles such as speaker, author, consultant, independent contractor (including research), employee, investor, advisory committee member, board member, review panelist, and investigator. If a potential speaker or author indicates a possible conflict of interest, the conflict will be resolved by choosing another speaker or author for that topical area, or the slides, handouts, and/or monograph will be reviewed and approved by a qualified commercially-disinterested peer.

Planning Committee Members
Patrick J. Shenot, MD
Scott A. MacDiarmid, MD, FRCPSC
Mickey Karram, MD
Paul DeLisle
Marco Cicero, PhD
Maja Drenovac, PharmD

DISCLOSURE OF FINANCIAL INTEREST SUMMARY


Faculty disclosures will be included in the course material.

No other speakers, authors, planners or content reviewers have any relevant financial relationships to disclose. No other speakers or authors will discuss off-label use of a product.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.


AMERICANS WITH DISABILITIES ACT


Vemco MedEd and Center for Independent Healthcare Education fully comply with the Americans With Disabilities Act. Please submit a written request at least 5 days prior to the meeting, and we will be glad to assist you with any special needs required to make this program accessible to you. Please email your request to cme@vemcomeded.com.


Jointly provided by
Center for Independent Healthcare Education and Vemco MedEd

Supported by an educational grant from
Astellas Scientific and Medical Affairs, Inc.

.




Home | About Us | What We Do | CME Portal | Register for Programs | Outcomes Reports | Contact Us | Legal | Privacy Statement
© 2024 Vemco MedEd, LLC I All Rights Reserved.